Kamal Hamed

Companies

• Spero Therapeutics, Inc.Chief Medical Officer Sep 14, 2022 to Feb 5, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• STSpero Therapeutics, Inc. SPRO788,117 shares²$878.8K at $1.11Feb 2, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 2, 2024Sold 28,075 shares at $1.37 of Spero Therapeutics, Inc.²
• Feb 1, 2024Granted 239,731 shares of Spero Therapeutics, Inc.²
• Sep 13, 2023Sold 39,496 shares at $1.27 of Spero Therapeutics, Inc.³
• Jun 12, 2023Granted 140,000 shares of Spero Therapeutics, Inc.⁴
• Feb 1, 2023Granted 265,957 shares of Spero Therapeutics, Inc.⁵
• Sep 12, 2022Granted 210,000 shares of Spero Therapeutics, Inc.⁶